Pyrazoles

Details Pyrazoles Pyrazoles

2006-03-31

2008-03-18

Anderson, Rebecca (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S406000, C546S135000, C548S374100

Reexamination Certificate

active

07345058

ABSTRACT:
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.

REFERENCES:
patent: 4093812 (1978-06-01), Rainer
patent: 4620865 (1986-11-01), Beck et al.
patent: 4792565 (1988-12-01), Shimotori et al.
patent: 5342835 (1994-08-01), Pepin et al.
patent: 5475132 (1995-12-01), Pepin et al.
patent: 2004/0122033 (2004-06-01), Nargund et al.
patent: 2004/0133011 (2004-07-01), Waddell et al.
patent: 2005/0080087 (2005-04-01), Pendri et al.
patent: 2612155 (1976-10-01), None
patent: 3713774 (1987-10-01), None
patent: 360701 (1990-03-01), None
patent: 2002003410 (2002-01-01), None
patent: WO 0170671 (2001-09-01), None
patent: WO 0190090 (2001-11-01), None
patent: WO 0190091 (2001-11-01), None
patent: WO 0190092 (2001-11-01), None
patent: WO 0190093 (2001-11-01), None
patent: WO 0190094 (2001-11-01), None
patent: WO 03059267 (2001-12-01), None
patent: WO 0244133 (2002-06-01), None
patent: WO 02076435 (2002-10-01), None
patent: WO 03043999 (2003-05-01), None
patent: WO 03044000 (2003-05-01), None
patent: WO 03044009 (2003-05-01), None
patent: WO 03051845 (2003-06-01), None
patent: WO 03065983 (2003-08-01), None
patent: WO 03075660 (2003-09-01), None
patent: WO 03104207 (2003-12-01), None
patent: WO 03104208 (2003-12-01), None
patent: WO 2004011410 (2004-02-01), None
patent: WO 2004033427 (2004-04-01), None
patent: WO 2004089470 (2004-04-01), None
patent: WO 2004041264 (2004-05-01), None
patent: WO 2004058741 (2004-07-01), None
patent: WO 2004065351 (2004-08-01), None
patent: WO 2004089415 (2004-10-01), None
patent: WO 2004089416 (2004-10-01), None
patent: WO 2004089470 (2004-10-01), None
patent: WO 2004089471 (2004-10-01), None
patent: WO 2004089896 (2004-10-01), None
patent: WO 2004103980 (2004-12-01), None
patent: WO 2004106294 (2004-12-01), None
patent: WO 2004112781 (2004-12-01), None
patent: WO 2004112782 (2004-12-01), None
patent: WO2005016877 (2005-02-01), None
R. A. De FronzoDrugs1999,58 Suppl. 1, 29.
S. E. InzucchiJAMA2002, 287, 360.
R. C. Turner et al.JAMA1999, 281, 2005.
M. Tadayyon and S. A. SmithExpert Opin. Investig. Drugs2003, 12, 307.
M. Salas and J. J. CaroAdv. Drug React. Tox. Rev. 2002, 21, 205-217.
E. S. Ford et al.JAMA2002, 287, 356.
Y. Kotolevtsev et al.Proc. Natl. Acad. Sci. USA1997, 94, 14924.
N. M. Morton et al.J. Biol. Chem. 2001, 276, 41293.
H. Masuzaki et al.Science, 2001, 294, 2166.
B. R. Walker et al.J. Clin. Endocrinol. Metab. 1995, 80, 3155.
R. C. Andrews et al.J. Clin. Enocrinol. Metab. 2003, 88, 285.
T. C. Sandeep et al.Proc. Natl. Acad. Sci USA2004, 101, 6734.
S. Diederich et al.Eur. J. Endocrinol. 2000, 142, 200.
R. A. S. Schweizer et al.Mol. Cell. Endocrinol. 2003, 212, 41.
H. H. Wassermann et al.Tetrahedron Lett. 1984, 25, 3743-3746.
S. Gelin et al.Synthesis1983, 566-568.
J. Svete et al.Synthesis1990, 70-72.
L. ClaisenLiebigs Ann. Chem. 1897, 297, 1-18.
L. Crombie et al.J. Chem. Soc. Perkin Trans. I1979, 464-471.
M. S. S. Palanki et al.J. Med. Chem. 2000, 43, 3995-4004.
M. T. Herrero et al.Tetrahedron2002, 58, 8581-8589.
J. R. Beck et al.J. Heterocycl. Chem. 1987, 24, 739-740.
G. Menozzi et al.J. Heterocycl. Chem. 1987, 24, 1669-1676.
H. Ohki et al.Bioorg. Med. Chem. Lett. 2002, 12, 3191-3193.
L. De Luca et al.J. Comb. Chem. 2003, 5, 465-471.
R. Zupet et al.J. Heterocycl. Chem. 1991, 28, 1731-1740.
D. E. Seitz et al.Tetrahedron Lett. 1995, 36, 1413-1416.
A. V. Rama Rao et al.Tetrahedron Lett. 1990, 31, 1439-42.
P. Kocienski et al.Tetrahedron Lett.1988, 29, 4481-4.
J. H. Dewar et al.J. Chem. Soc. 1961, 3254-3260.
A. X. Wang et al.Bioorg. Med. Chem. Lett. 1998, 8, 2787-2792.
T. A. Elmaati et al.Pol. J. Chem. 2002, 76, 945-952.
Chemical Abstracts AN 2002:501464.
G. Giacomelli et al.Eur. J. Org. Chem. 2003, 537-541.
F. B. DainsChem. Ber. 1902, 35, 2496-2500.
F. B. Dains et al.J. Am. Chem. Soc. 1909, 31, 1148-1157.
F. B. Dains et al.J. Am. Chem. Soc. 1918, 40, 562-569.
O. S. WolfbeisChem. Ber. 1981, 114, 3471-3484.
Chemical Abstracts AN 1987:458919.
F. B. Dains et al.J. Am. Chem. Soc. 1916, 38, 1515.
A. N. Borisevich et al.Ukrainskii Khimicheskii Zhurnal1986, 52, 641-7.
M. Kopp et al.J. Heterocycl. Chem. 2001, 38, 1045-1050.
J. SvetlikHeterocycles1984, 22, 2513-2516.
J. R. Beck et al.J. Heterocycl. Chem. 1987, 24, 267-270.
T. Luebbers et al.Bioorg. Med. Chem. Lett. 2000, 10, 821-826.
X.-J. Wang and K. GrozingerTetrahedron Lett. 2000, 41, 4713-4716.
F. Bondavalli et al.J. Med. Chem. 2002, 45, 4875-4887.
S. Schenone et al.Bioorg. Med. Chem. Lett. 2001, 11, 2529-2531.
P. Seneci et al.Synth. Commun. 1999, 29, 311-341.
“Comprehensive Organic Transformations: A Guide to Functional Group Preparations” [R. C. Larock, VCH Publishers, Inc. New York, 1989, pp. 685.
“Comprehensive Organic Transformations: A Guide to Functional Group Preparations” [R. C. Larock, VCH Publishers, Inc. New York, 1989, pp. 694-695.
“Comprehensive Organic Transformations: A Guide. to Functional Group Preparations” [R. C. Larock, VCH Publishers, Inc. New York, 1989, p. 768.
J. March, 3rdEdition, John Wiley & Sons, Inc. New York, 1985], on pp. 437-439.
J. March, 3rdEdition, John Wiley & Sons, Inc. New York, 1985], on pp. 823-824.
H. Emtenäs et al.J. Org. Chem. 2001, 26, 6756-6761.
J. Timberlake and J. Stowell; S. Patai Ed.; John Wiley & Sons, Ltd. London 1975, 69-107.
N. I. Ghali et al.J Org. Chem. 1981, 46, 5413-5414.
J. Viret et al.Tetrahedron1987, 43, 891-894.
L. F. Audrieth and L. H. DiamondJ. Am. Chem. Soc. 1954, 76, 4869-4871.
A. Koziara et al.Synth. Commun. 1995, 25, 3805-3812.
N. Brosse et al.Tetrahedron Lett. 2000, 41, 205-207.
J. Fugger et al.J. Am. Chem. Soc. 1955, 77, 1843-1848.
S. Zawadzki et al.Synthesis1987, 485-487.
B. Mlotkowska and Z. ZwierzakTetrahedron Lett. 1978, 19, 4731-4734.
M. S. Gibson; S. Patai Ed.; John Wiley & Sons, Ltd. London 1968, 37-77.
J. March, 3rdEdition, John Wiley & Sons, Inc. New York, 1985, 1153-1154.
R. C. Larock, VCH Publishers, Inc. New York, 1989, 1061-1063.
L. A. Paquette and R. F. Doehner, Jr.J. Org. Chem. 1980, 45, 5105-5113.
F. W. Vierhapper and E. L. ElielJ. Org. Chem. 1975, 40, 2734-2742.
L. A. Cohen and B. WitkopJ. Am. Chem. Soc. 1955, 77, 6595-6600.
H. W. Geluk and J. L. M. A. SchlatmannTetrahedron1968, 24, 5369-5377.
R. C. Larock, VCH Publishers, Inc. New York, 1989[ on pp. 421-423.
R. G. JonesJ. Am. Chem. Soc. 1952, 74, 4889-4891.
N. J. Cusack et al.J. Chem. Soc. C1971, 1501-1507.

Affiliated with

Also associated with

Rating

Pyrazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazoles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3979405